Cardiac Involvement in Systemic Lupus Erythematosus

Handbook of Systemic Autoimmune Diseases

Volumn 1, Issue , 2003, Pages 145-161

  Doria, Andrea ^a   Petri, Michelle ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67649646242     PISSN: 15715078     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1571-5078(03)01010-9     Document Type: Review

References (179)

1. Abu-Shakra M., Urowitz M.B., Gladman D.D., et al. Mortality studies in systemic lupus erythematosus. Results from a single centre. I. Causes of death. J. Rheumatol. 22 (1995) 1259
2. Amital H., Langevitz P., Levy Y., et al. Valvular deposition of antiphospholipid antibodies in the antiphospholipid syndrome: a clue to the origin of the disease. Clin. Exp. Rheumatol. 17 (1999) 99
3. Asherson R.A., Khamashta M.A., Baguley E., et al. Myocardial infarction and antiphospholipid antibodies in SLE and related disorders. Q. J. Med. 73 (1989) 1100
4. Badui E., Garcia-Rubi D., Robles E., et al. Cardiovascular manifestations in systemic lupus erythematosus. Prospective study of 100 patients. Angiology 36 (1985) 452
5. Barzizza F., Venco A., Grandi A.M., et al. Mitral valve prolapse in systemic lupus erythematosus. Clin. Exp. Rheumatol. 5 (1987) 59
6. Berg G., Bodet J., Webb K., et al. Systemic lupus erythematosus presenting as isolated congestive heart failure. J. Rheumatol. 12 (1985) 1182
7. Bharati S., de la Fuente D.J., and Kallen R.J. Conduction system in systemic lupus erythematosus with atrioventricular block. Am. J. Cardiol. 35 (1975) 299
8. Biazarian S.D., Taylor A.J., Brezinski D., et al. High grade atrioventricular heart block in an adult with systemic lupus erythematosus: the association of nuclear RNP (U1 RNP) antibodies, a case report, and a review of the literature. Arthritis Rheum. 32 (1989) 1170
9. Bidani A.K., Roberts J.L., Schwartz M.M., et al. Immunopathology of cardiac lesions in fatal systemic lupus erythematosus. Am. J. Med. 69 (1980) 849
10. Borba E.F., and Bonfa E. Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity and anticardiolipin antibodies. Lupus 6 (1997) 533
11. Borba E.F., Bonfa E., and Vinagre C.G. Impaired metabolism of artificial chylomicronis in systemic lupus erythematosus (abstract). Arthritis Rheum. 41 (1998) S79
12. Borenstein D.G., Fye W.B., Arnett F.C., et al. The myocarditis of systemic lupus erythematosus: association with myositis. Ann. Intern. Med. 89 (1978) 619
13. Brigden W., Bywaters E.G.L., Lessof M.H., et al. The heart in systemic lupus erythematosus. Br. Heart J. 22 (1960) 1
14. Brucato A., Buyon J.P., Horsfall A.C., et al. Fourth international workshop on neonatal lupus syndromes and the Ro/SSA-La/SSB System. Clin. Exp. Rheumatol. 17 (1999) 130
15. Brucato A., Frassi M., Franceschini F., et al. Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women. Arthritis Rheum. 44 (2001) 1832
16. Brucato A., Doria A., Frassi M., et al. Pregnancy outcome in 100 women with autoimmune diseases and anti-Ro/SSA antibodies: a prospective controlled study. Lupus 11 (2002) 716 It is the first prospective study on the risk of CCHB in newborns of mothers with anti-Ro/SSA antibodies
17. Bruce I.N., Urowitz M.B., Galdman D.D., et al. Natural history of hypercholesterolemia in systemic lupus erythematosus. J. Rheumatol. 26 (1999) 2137
18. Bruce I.N., Burns R.J., Gladman D.D., et al. Single photon emission computed tomograpy dual isotope myocardial perfusion imaging in women with systemic lupus erythematosus. I. Prevalence and distribution of abnormalities. J. Rheumatol. 27 (2000) 2372
19. Bruce I.N., Gladman D.D., and Urowitz M.B. Premature atherosclerosis in systemic lupus erythematosus. Rheum. Dis. Clin. N. Am. 26 (2000) 257 Bruce and co-authors extensively reviewed clinical and subclinical atherosclerosis in SLE as well as traditional and non-traditional risk factors for coronary artery disease
20. Bulkley B.H., and Roberts W.C. The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy: a study of 36 necropsy patients. Am. J. Med. 58 (1975) 243 This paper is a milestone in the modern history of SLE. It deals with the histopathologic changes of lupus carditis including those induced by corticosteroids
21. Carette S. Cardiopulmonary manifestations of systemic lupus erythematosus. Rheum. Dis. Clin. N. Am. 14 (1988) 135
22. Castier M.B., Albuquerque E.M., Menezes M.E., et al. Cardiac tamponade in systemic lupus erythematosus. Report of four cases. Arq. Bras. Cardiol. 75 (2000) 446
23. Cervera R., Font J., Pare C., et al. Cardiac disease in systemic lupus erythematosus: prospective study of 70 patients. Ann. Rheum. Dis. 51 (1992) 156
24. Cervera R., Khamashta M.A., Font J., et al. Systemic lupus erythematosus: clinical and immunonologic patterns of disease expression in a cohort of 1000 patients. The European working party on systemic lupus erythematosus. Medicine (Baltimore) 72 (1993) 113
25. Cervera R., Khamashta M.A., Font J., et al. Morbidity and mortality in systemic lupus erythematosus during a 5 year period. A multicenter prospective study of 1000 patients. European Working Party on Systemic lupus erythematosus. Medicine (Baltimore) 778 (1999) 167 This paper is a 5-year prospective study on clinical manifestations in a very large group of patients
26. Chartash E.K., Lans D.M., Paget S.A., et al. Aortic insufficiency and mitral regurgitation in patients with systemic lupus erythematosus and the antiphospholipid syndrome. Am. J. Med. 86 (1989) 407
27. Chia B.L., Mah E.P., and Feng P.H. Cardiovascular abnormalities in systemic lupus erythematosus. J. Clin. Ultrasound 9 (1981) 237
28. Clarke R., Daly L., Robinson K., et al. Hyperhomocysteinemia. An independent risk factor for vascular disease. N. Engl. J. Med. 324 (1991) 1149
29. Collins R.L., Turner R.A., Nomeir A.M., et al. Cardiopulmonary manifestations of systemic lupus erythematosus. J. Rheumatol. 5 (1978) 299
30. Comens S.M., Alpert M.A., Sharp G.C., et al. Frequency of mitral valve prolapse in systemic lupus erythematosus, progressive systemic sclerosis and mixed connective tissue disease. Am. J. Cardiol. 63 (1989) 369
31. Comi{dotless}́n-Colet J., Sánches-Corral M.A., Alegre-Sancho J.J., et al. Complete heart block in an adult with systemic lupus erythematosus and recent onset of hydroxychloroquine therapy. Lupus 10 (2001) 59
32. Copeland G.D., Von Capeller D., and Stern T.N. Systemic lupus erythematosus: a clinical report of 47 cases with pathologic findings in 18. Am. J. Med. Sci. 236 (1958) 318
33. Crozier I.G., Li E., Miline M.J., et al. Cardiac involvement in systemic lupus erythematosus detected by echocardiography. Am. J. Cardiol. 65 (1990) 1145
34. Dajee H., Hurley E.J., and Szarnicki R.J. Cardiac valve replacement in systemic lupus erythematosus: a review. J. Thorac. Cardiovasc. Surg. 85 (1983) 718
35. Das S.K., and Cassidy J.T. Anti-heart antibodies in patients with systemic lupus erythematosus. Am. J. Med. Sci. 265 (1973) 275
36. D'Cruz D., Khamashta M., and Huges G. Cardiovascular manifestation of systemic lupus erythematosus. In: Wallace D., and Hahn B.H. (Eds). Dubois' lupus erythematosus (2001), Lippincott Williams & Wilkins, Philadelphia p. 645
37. De Catenina R., d'Ascanio A., Mazzone A., et al. Prevalence of anticardiolipin antibodies in coronary artery disease. Am. J. Cardiol. 65 (1990) 922
38. Del Papa N., Raschi E., Moroni G., et al. Anti-endothelial cell IgG fractions from systemic lupus erythematosus patients bind to human endothelial cells induce a pro-adhesive and a pro-inflammatory phenotype in vitro. Lupus 8 (1999) 423
39. Del Rio A., Vazquez J.J., Sobrino J.A., et al. Myocardial involvement in systemic lupus erythematosus. A noninvasive study of left ventricular function. Chest 74 (1978) 414
40. Disla E., Rhim H.R., Reddy A., et al. Reversible cardiogenic shock in a patients with lupus myocarditis. J. Rheumatol. 20 (1993) 2174
41. Doherty N.E., and Siegel R.J. Cardiovascular manifestation of systemic lupus erythematosus. Am. Heart J. 110 (1985) 1257
42. Doherty III N.E., Feldman G., Maurer G., et al. Echocardiographic findings in systemic lupus erythematosus. Am. J. Cardiol. 61 (1988) 1144
43. Doria A., Shoenfeld Y., Wu R., et al. Risk factors for subclinical atherosclerosis in a prospective cohort of patients with Systemic Lupus Erythematosus. Ann. Rheum. Dis. 62 (2003) 1071 In this paper the first prospective evaluation of risk factors for subclinical atherosclerosis has been carried out
44. Dubois E.L., and Tuffanelli D.L. Clinical manifestation of systemic lupus erythematosus. Computer analysis of 520 cases. JAMA 190 (1964) 104
45. Eiken P.W., Edwards W.D., Tazelaar H.D., et al. Surgical pathology of nonbacterial thrombotic endocarditis in 30 patients, 1985-2000. Mayo Clin. Proc. 76 (2001) 1204
46. Elkayam U., Weiss S., and Laniado S. Pericardial effusion and mitral valve involvement in systemic lupus erythematosus: echocardiographic study. Ann. Rheum. Dis. 36 (1977) 349
47. Englund J.A., and Lucas Jr. R.V. Cardiac complications in children with systemic lupus erythematosus. Pediatrics 72 (1983) 724
48. Esdaile J.M., Abrahamowicz M., Grodzicky T., Li Y., et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum. 44 (2001) 2231
49. Estes D., and Christian C.L. The natural history of systemic lupus erythematosus by prospective analysis. Medicine (Baltimore) 50 (1971) 85 This paper is a milestone in the modern history of lupus. It is a clinical study
50. Ettinger W.H., Glodberg A.P., Applebaum-Bowden D., et al. Dyslipoproteinemia in systemic lupus erythematosus. Effect of corticosteroids. Am. J. Med. 83 (1987) 503
51. Fairfax M.J., Osborn T.G., Williams G.A., et al. Endomyocardial biopsy in patients with systemic lupus erythematosus. J. Rheumatol. 15 (1988) 593
52. Falcão C.A., Alves I.C., Chahade W.H., et al. Echocardiographic abnormalities and antiphospholipid antibodies in patients with systemic lupus erythematosus. Arq. Bras. Cardiol. 79 (2002) 285
53. Feldman A.M., and McNamara D. Engl. J. Med. 343 (2000) 1388
54. Fermo I., D'Angelo S.V., Paroni R., et al. Prevalence of moderate hyperhomocysteinemia in patients with early onset venous and arterial occlusive disease. Ann. Intern. Med. 123 (1995) 747
55. Fonseca E., Crespo M., and Sobrino J.A. Complete heart block in an adult with systemic lupus erythematosus. Lupus 3 (1994) 129
56. Ford P.M., Ford S.E., and Lillicrap D.P. Association of lupus anticoagulant with severe valvular heart disease in systemic lupus erythematosus. J. Rheumatol. 15 (1988) 597
57. Fox I.S., Spence A.M., Wheelis R.F., et al. Cerebral embolism in Libman-Sacks endocarditis. Neurology 30 (1980) 487
58. Fukumoto S., Tsumagari T., Kinjo M., et al. Coronary atherosclerosis in patients with systemic lupus erythematosus at autopsy. Acta Pathol. Jpn 37 (1987) 1
59. Galve E., Candell-Riera J., Pigrau C., et al. Prevalence, morphologic types and evolution of cardiac valvular disease in systemic lupus erythematosus. N. Engl. J. Med. 319 (1988) 817
60. Gentile R., Laganaà B., Tubani M., et al. Assessment of echocardiographic abnormalities in patients with systemic lupus erythematosus: correlation with levels of antiphospholipid antibodies. Ital. Heart J. 1 (2000) 487
61. Giunta A., Picillo U., Maione S., et al. Spectrum of cardiac involvement in systemic lupus erythematosus: echocardiographic, echo-Doppler observations and immunologivcal investigation. Acta. Cardiol. 48 (1993) 183
62. Gladman D.D., and Urowitz M.B. Morbidity in systemic lupus erythematosus. J. Rheumatol. 14 (1987) 223
63. Gómez-Barrado J.J., Garci{dotless}́a-Rubira J.C., Polo Ostáriz M.A., et al. Complete atrioventricular block in a woman with systemic lupus erythematosus. Int. J. Cardiol. 82 (2002) 289
64. Gordon R.J., Weilbaecher D., Davy S.M., et al. Valvulitis involving a bioprosthetic valve in a patients with systemic lupus erythematosus. J. Am. Soc. Echocardiogr. 9 (1996) 104
65. Griffith G.C., and Vural I.L. Acute and subacute disseminated lupus erythematosus: a correlation of clinical and post-mortem findings in eighteen cases. Circulation 3 (1951) 492
66. Gross L. Cardiac lesions in Libman-Sacks disease, with consideration of its relationship to acute diffuse lupus erythematosus. Am. J. Pathol. 16 (1940) 375
67. Haider Y.S., and Roberts W.C. Coronary arterial disease in systemic lupus erythematosus: quantification of degrees of narrowing in 22 necropsy patients (21 women) ages 16 to 37 years. Am. J. Med. 70 (1981) 775
68. Hakim J.P., Mehta A., Jain A.C., et al. Mitral valve replacement and repair. Report of 5 patients with systemic lupus erythematosus. Tex. Heart Inst. J. 28 (2001) 47
69. Harvey A.M., Shulman L.E., Tumulty P.A., et al. Systemic lupus erythematosus: review of the literature and clinical analysis of 138 cases. Medicine 33 (1954) 291 This is the oldest clinical study of the modern era in the history of SLE
70. Heibel R.H., O'Toole J.D., Curtiss E.I., et al. Coronary arteritis in systemic lupus erythematosus. Chest 69 (1976) 700
71. Hejtmancilk M.R., Wright J.C., Quint R., et al. The cardiovascular manifestation of systemic lupus erythematosus. Am. Heart J. 68 (1964) 119
72. Hogarth M.B., Judd L., Mathias C.J., et al. Cardiovascular autonomic function in systemic lupus erythematosus. Lupus 11 (2002) 308
73. Homcy C.J., Libertson R.R., Fallon J.T., et al. Ischemic heart coronary vasculitis in systemic lupus erythematosus in the young patient: report of six cases. Am. J. Cardiol. 49 (1982) 478
74. Hosepund J.D., Montanaro A., Hart M.V., et al. Myocardial perfusion abnormalities in asymptomatic patients with systemic lupus erythematosus. Am. J. Med. 77 (1984) 286
75. Humphreys E.M. The cardiac lesions of acute disseminated lupus erythematosus. Ann. Intern. Med. 28 (1948) 12
76. Ilowite N.T., Samuel P., Ginzler E., et al. Dyslipoproteinemia in pediatric systemic lupus erythematosus. Arthritis Rheum. 31 (1988) 859
77. Ishida R., Murata Y., Sawada Y., et al. Thallium-201 myocardial SPECT in patients with collagen disease. Nucl. Med. Commun. 21 (2000) 729
78. Ito M., Kagiyama Y., Omura I., et al. Cardiovascular manifestation of systemic lupus erythematosus. Jpn. Circ. J. 43 (1979) 985
79. Jacobson E.J., and Reza M.J. Constrictive pericarditis in systemic lupus erythematosus: demonstration of immunoglobulins in the pericardium. Arthritis Rheum. 21 (1978) 972
80. James T.N., Rupe C.E., and Monto R.W. Pathology of the cardiac conduction system in systemic lupus erythematosus. Ann. Intern. Med. 63 (1965) 402
81. Jensen-Urstad K., Svenungsson E., de Faire U., et al. Cardiac valvular abnormalities are frequent in systemic lupus erythematosus with manifest arterial disease. Lupus 11 (2002) 744
82. Jessar R.A., Lamont-Havers R.W., and Ragan C. Natural history of lupus erythematosus disseminatus. Ann. Intern. Med. 38 (1953) 717
83. Jolles P.R., and Tatum J.L. SLE myocarditis. Detection by Ga-67 citrate scintigraphy. Clin. Nucl. Med. 21 (1996) 284
84. Jonsson H., Nived O., and Surfelt G. Outcome in systemic lupus erythematosus: a prospective study of patients from a defined population. Medicine 68 (1989) 141
85. Kahan A., Amor B., De Vernejoul F., et al. Libman-Sacks endocarditis. The diagnostic importance of two-dimensional echocardiography. Br. J. Rheum. 24 (1985) 187
86. Kahl L.E. The spectrum of pericardial tamponade in systemic lupus erythematosus: report of ten patients. Arthritis Rheum. 35 (1992) 1343
87. Kannel W.B., and Sorlie P. Some health benefits of physical activity. Arch. Intern. Med. 139 (1979) 857
88. Kao A.H., and Manzi S. How to manage patients with cardiopulmonary disease?. Best Pract. Res. Clin. Rheumatol. 16 (2002) 211
89. Kaplanski G., Cacoub B., Farnarier C., et al. Increased soluble vascular cell adhesion molecule 1 concentration in patients with primary or lupus erythematosus related antiphospholipid syndrome: correlation with the severity of thrombosis. Arthritis Rheum. 43 (2000) 55
90. Kattwinkel N., Villanueva A.G., Labib S.B., et al. Myocardial infarction caused by cardiac microvasculopathy in a patient with the primary antiphospholipid syndrome. Ann. Intern. Med. 116 (1992) 974
91. Khamashta M.A., Cervera R., Asherson R.A., et al. Association of antibodies against phospholipid with heart valve disease in systemic lupus erythematosus. Lancet 335 (1990) 1541
92. Kindig J.R., and Goodman M.R. Clinical utility of pericardial fluid pH determination. Am. J. Med. 75 (1983) 1077
93. Kinney E.L., Wynn J., Ward S., et al. Ruptured chordae tendinae: its association with systemic lupus erythematosus. Arch. Pathol. Lab. Med. 104 (1980) 595
94. Klinkhoff A.V., Thompson C.R., Reid G.D., et al. M-mode and two-dimensional echocardiogrphic abnormalities in systemic lupus erythematusus. JAMA 253 (1985) 3273
95. Kong T.Q., Kellum R.E., and Haserich J.R. Clinical diagnosis of cardiac involvement in systemic lupus erythematosus: a correlation of clinical and autopsy findings in thirty. Circulation 26 (1962) 7
96. Lahita R.G., Rivkin E., Cavanagh I., et al. Low levels of total cholesterol, high-density lipoprotein, and apolipoprotein A1 in association with anticardiolipin antibodies in patients with systemic lupus erythematosus. Arthritis Rheum. 36 (1993) 1566
97. Lash A.D., Wittman A.L., and Quisimoro Jr. F.P. Myocarditis in mixed connective tissue disease: clinical and pathologic study of three cases and review of literature. Semin. Arthritis Rheum. 15 (1986) 288
98. Lehman T.J.A., Mc Curdy D.K., Bernstein B.H., et al. Systemic lupus erythematosus in the first decade of life. Pediatrics 83 (1989) 235
99. Leong K.H., Koh E.T., Feng P.H., et al. Lipid profiles in patients with systemic lupus erythematosus. J. Rheumatol. 21 (1994) 1264
100. Lerman B.B., Thomas L.C., Abrams G.D., et al. Aortic stenosis associated with systemic lupus erythematosus. Am. J. Med. 72 (1982) 707
101. Leung W.H., Wong K.L., Lau C.P., et al. Cardiac abnormalities in systemic lupus erythematosus: a prospective M-mode, cross-sectional and Doppler echocardiographic study. Int. J. Cardiol. 27 (1990) 367
102. Leung W.H., Wong K.L., Llau C.P., et al. Association between antiphospholipid antibodies and cardiac abnormalities in patients with systemic lupus erythematosus. Am. J. Med. 89 (1990) 411
103. Li R., Cai J., Tegeler C., Sorlie P., et al. Reproducibility of extracranial carotid atherosclerotic lesion assessed by B-mode ultrasound: the Artherosclerosis Risk in Communities Study. Ultrasound Med. Biol. 22 (1996) 791
104. Libman E., and Sacks B. A hitherto undescribed form of valvular and mural endocarditis. Arch. Intern. Med. 33 (1924) 701 It is the first original description of verrucous endocarditis, later termed Libman-Sacks endocarditis
105. Logar D., Kveder T., Rozman B., et al. Possible association between anti-Ro antibodies and myocarditis or cardiac conduction defects in adults with systemic lupus erythematosus. Ann. Rheum. Dis. 49 (1990) 627
106. Louthrenoo W., Ruttanaumpawan P., Aramrattana A., et al. Cardiovascular autonomic nervous system dysfunction in patients with rheumatoid arthritis and systemic lupus erythematosus. Q. J. Med. 92 (1999) 97
107. Luce E.B., Montgomery M.T., and Redding S.W. The prevalence of cardiac valvular pathosis in patients with systemic lupus erythematosus. Oral Surg. Oral Med. Oral Pathol. 70 (1990) 590
108. MacGregor A.J., Dhillon V.B., Binder A., et al. Fastings lipids and antiacardiolipin antibodies as risk factors for vascular disease in systemic lupus erythematosus. Ann. Rheum. Dis. 51 (1992) 152
109. Mandell B.F. Cardiovascular involvement in systemic lupus erythematosus. Semin. Arthritis Rheum. 17 (1987) 126
110. Manzi S., Meilahn E.N., Rairie J.E., et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with Framingham Study. Am. J. Epidemiol. 145 (1997) 408 This study reports the incidence of coronary artery disease in a very large cohort of lupus patients and an extensive evaluation of risk factors
111. Manzi S., Selzer F., Sutton-Tyrrel K., et al. Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Arthritis Rheum. 42 (1999) 51 In this study, Manzi and co-authors examined the prevalence of subclinical atherosclerosis in SLE. The evaluation of risk factors was also reported
112. Martinez-Costa X., Ordi J., Barbera J., et al. High grade atrioventricular heart block in 2 adults with systemic lupus erythematosus. J. Rheumatol. 18 (1991) 1926
113. Matayoshi A.H., Dhond M.R., and Laslett L.J. Multiple coronary aneurysms in a case of systemic lupus erythematosus. Chest 116 (1999) 1116
114. Matsuura E., Igarashi Y., Yasuda T., et al. Anticardiolipin antibodies recognize (2-glycoprotein I structure altered by interacting with an oxigen modified solid phase surface. J. Exp. Med. 179 (1994) 457
115. Meissner M., Sherer Y., Levy Y., et al. Intravenous immunoglobulin therapy in a patient with lupus serositis and nephritis. Rheumatol. Int. 19 (2000) 199
116. Meller J., Conde C.A., Deppisch L.M., et al. Myocardial infarction due to coronary atherosclerosis in three young adults with systemic lupus erythematosus. Am. J. Cardiol. 35 (1975) 309
117. Metz D., Jolly D., Graciet-Richard J., et al. Prevalence of valvular involvement in systemic lupus erythematosus and association with antiphospholipid syndrome: a matched echocardiographic study. Cardiology 85 (1994) 129
118. Mevorach D., Raz E., Shalev O., et al. Complete heart block and seizure in an adult with systemic lupus erythematosus. Arthritis Rheum. 36 (1993) 259
119. Moder G.K., Miller T.D., and Tazelaar H.D. Cardiac involvement in Systemic lupus erythematosus. Mayo Clin. Proc. 74 (1999) 275
120. Morin A.M., Boyer A.S., Nataf P., et al. Mitral insufficiency caused by systemic lupus erythematosus requiring valve replacement: three case reports and a review of the literature. Thorac. Cardiovasc. Surg. 44 (1996) 313
121. Mourguet A.J., Sandrock D., Stille-Siegener M., et al. Indium-111-antimyosin Fab imaging to demonstrate myocardial involvement in systemic lupus erythematosus. J. Nucl. Med. 36 (1995) 1432
122. Murpy J.J., and Leach I.H. Findings at necropsy in the heart of patients with the primary antiphospholipid syndrome. Br. Heart J. 62 (1989) 61
123. Naarendorp M., Kerr L.D., Khan A.S., et al. Dramatic improvement of left ventricular function after cytotoxic therapy in lupus patients with acute cardiomyopathy: report of 6 cases. J. Rheumatol. 26 (1999) 2257
124. Nesher G., Ilany J., Rosemann D., et al. Valvular dysfunction in antiphospholipid syndrome: prevalence, clinical features, and treatment. Semin. Arthritis Rheum. 27 (1997) 27
125. Nihoyannopoulos P., Gomez P.M., Joshi J., et al. Cardiac abnormalities in systemic lupus erythematosus. Association with raised anticardiolipin antibodies. Circulation 82 (1990) 369
126. Nobrega T.P., Klodas E., Breen J.F., et al. Giant coronary artery aneurysm in systemic lupus erythematosus. Cathet. Cardiovasc. Diagn. 39 (1996) 75
127. O'Leary D.H., Polak J.F., Kronmal R.A., et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N. Eng. J. Med. 340 (1999) 14
128. Omdal R., Lunde P., Rasmussen K., et al. Transesophageal and trans thoracic echocardiography and Doppler-examination in systemic lupus erythematosus. Scand. J. Rheumatol. 30 (2001) 275
129. Ong M.L., Veerapen K., Chambers J.B., et al. Cardiac abnormalities in systemic lupus erythematosus: prevalence and relationship to disease activity. Int. J. Cardiol. 34 (1992) 69
130. Petri M., Perez-Gutthann S., Spence D., et al. Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am. J. Med. 93 (1992) 513 Petri and co-authors studied the risk factors for coronary artery disease in a very large cohort of lupus patients
131. Petri M., Spence D., Bone L.R., et al. Coronary artery disease risk factors in the Johns Hopkins Lupus Cohort: Prevalence, recognition by patients and preventing pratices. Medicine 71 (1992) 291
132. Petri M., Lakatta C., Magder L., et al. Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis. Am. J. Med. 96 (1994) 254
133. Petri M., Roubenoff R., Dallal G.E., et al. Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus. Lancet 348 (1996) 1120
134. Petri M. Detection of coronary artery disease and the role of traditional risk factors in the Hopkins Lupus Cohort. Lupus 9 3 (2000) 170
135. Petri M. Hopkins Lupus Cohort. 1999 update. Rheum. Dis. Clin. N. Am. 26 (2000) 199
136. Phadke K.V., Phillips R.A., Clarke D.T., et al. Antiacardiolipin antibodies in ischemic heart disease: marker or myth?. Br. Heart J. 69 (1993) 391
137. Pritzker M.R., Ernst J.D., Caudill C., et al. Acquired aortic stenosis in systemic lupus erythematosus. Ann. Intern. Med. 93 (1980) 434
138. Rahman P., Urowitz M.B., Galdman D.D., et al. Contribution of traditional risk factors to coronary artery disease in patients with systemic lupus erythematosus. J. Rheumatol. 26 (1999) 2363
139. Ramonda R., Doria A., Villanova C., et al. Évaluation de l'atteinte cardiaque au cours du lupus érythémateux disséminé: étude clinique et échocardiographique. Rev. Rhum. Mal. Ostéoartic. 59 12 (1992) 790
140. Rantapää-Dahlquist S., Neumann-Andersen G., Backman C., et al. Echocardiographic findings, lipids and lipoprotein (a) in patients with systemic lupus erythematosus. Clin. Rheumatol. 16 (1997) 140
141. Ratliff N.B., Estes M.L., Myles J.L., et al. Diagnosis of chloroquine cardiomyopathy by endomyocardial biopsy. N. Engl. J. Med. 316 (1987) 191
142. Ridker P.M. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 103 (2001) 1813
143. Ridker P.M., Cushman M., Stampfer M.J., et al. Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men. N. Engl. J. Med. 336 (1997) 973
144. Roberts W.C., and High S.T. The heart in systemic lupus erythematosus. Curr. Probl. Cardiol. 24 (1999) 1
145. Roditi G.H., Hartnell G.C., and Cohen M.C. MRI changes in myocarditis-evaluation with spin echo, cine MR angiography and contrast enhanced spin echo imaging. Clinical Radiology 55 (2000) 752
146. Roldan C.A., Shively B.K., and Crawford M.H. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N. Eng. J. Med. 335 (1996) 1424
147. Roman M.J., Salmon J.E., Sobel R., et al. Prevalence and relation to risk factors of carotid atherosclerosis and left ventricular hypertrophy in systemic lupus erythematosus and antiphospholipid antibody syndrome. Am. J. Cardiol. 87 (2001) 663
148. In: Ropes M.W. (Ed). Systemic lupus erythematosus (1976), Harvard University Press, Cambridge, MA
149. Rosenthal T., Neufeld H., Kishon Y., et al. Myocardial infarction in a young woman with systemic lupus erythematosus. Angiology 31 (1980) 573
150. Rosner S., Ginzler E.M., Diamond H.S., et al. A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death. Arthritis Rheum. 25 (1982) 612
151. Rubin L.A., Urowitz M.B., and Gladman D.D. Mortality in systemic lupus erythematosus: the bimodal pattern revisited. Q. J. Med. 55 (1985) 87
152. Schillaci O., Laganà B., Danieli R., et al. Technetium-99m sestamibi single-photon emission tomography detects subclinical myocardial perfusion abnormalities in patients with systemic lupus erythematosus. Eur. J. Nucl. Med. 26 (1999) 713
153. Shapiro R.F., Gamble C.N., Wiesner K.B., et al. Immunopathogenesis of Libman-Sacks endocarditis. Assessment by light and immunofluorescent microscopy in two cases. Ann. Rheum. Dis. 36 (1977) 508
154. Shearn M.A. The heart in systemic lupus erythematosus. Am. Heart J. 58 (1959) 452
155. Sherer Y., Levy Y., and Shoenfeld Y. Marked improvement of severe cardiac dysfunction after one course of intravenous immunoglobulin in a patient with systemic lupus erythematosus. Clin. Rheumatol. 18 (1999) 238
156. Shively B.K. Transesophageal echocardiography (TEE) evaluation of the aortic valve, left ventricular outflow tract, and pulmonic valve. Cardiol. Clin. 18 (2000) 711
157. Shoenfeld Y., George J., Sherer Y., et al. Atherosclerosis: evidence for the role of autoimmunity. In: Shoenfeld Y., Harats D., and Wick G. (Eds). Atherosclerosis and Autoimmunity. Elsevier Science (2001) 139-142 In this chapter autoimmune mechanisms involved in atherosclerosis have been extensively reviewed
158. Simantov R., LaSale S.M., Lo S.K., et al. Activation of cultured vascular endothelial cells by antiphospholipid antibodies. J. Clin. Invest. 96 (1995) 2211
159. Stevens M.B. Systemic lupus erythematosus and the cardiovascular system: the heart. In: Lahita R.G. (Ed). Systemic lupus erythematosus (1992), Churcill Livingstone, New York p. 707
160. Straaton K.V., Chatham W.W., Reveille J.D., et al. Clinically significant valvular heart disease in systemic lupus erythematosus. Am. J. Med. 85 (1988) 645
161. Sturfelt G., Eskilsson J., Nived O., et al. Cardiovascular disease in systemic lupus erythematosus: a study of 75 patients from a defined population. Medicine 71 (1992) 216
162. Sun S.S., Shiau Y.C., Tsai S.C., et al. The role of technetium-99m sestamibi myocardial perfusion single-photon emission tomography (SPECT) in the detection of cardiovascular involvement in systemic lupus erythematosus patients with non-specific chest complaints. Rheumatology 40 (2001) 1106
163. Svenungsson E., Jensen-Urstad K., and Heimbürger M. Risk factors for cardiovascular disease in systemic lupus erythematosus. Circulation 104 (2001) 1887 In this study, many novel risk factors for subclinical atherosclerosis have been evaluated
164. Thandroyen F.T., Matisonn R.E., and Weir E.K. Severe aortic incompetence caused by systemic lupus erythematosus: a case report. S. Afr. Med. J. 54 (1978) 166
165. Tumulty P.A., and Harvey A.M. The clinical course of disseminated lupus erythematosus: an evaluation of Osler's contribution. Bull. Johns Hopkins Hosp. 85 (1949) 47
166. Urowitz M.B., Bookman A.A.M., Koehler B.E., et al. The bimodal mortality pattern of systemic lupus erythematosus. Am. J. Med. 60 (1976) 221 This is the paper which provides the first clinical evidence of early atherosclerosis
167. Vaarala O., Alfthan G., Jauhiainen M., et al. Cross-reaction between antibodies to oxidized low-density lipoprotein and to cardiolipin in systemic lupus erythematosus. Lancet 341 (1993) 923
168. Vianna J.L., Khamashta M.A., Ordi-Ros J., et al. Comparison of the primary and secondary antiphospholipid syndrome: an European Multicenter Study of 114 patients. Am. J. Med. 96 (1994) 3
169. Von Felt J.M. Coronary electron beam computed tomography (EBCT) in 13 patients with 2 or more cardiovascular risk factors. Arthritis Rheum. 41 (1998) S139
170. Wallace D.J., Podell T., Weiner J., et al. Systemic lupus erythematosus-survival patterns. Experience with 609 patients. JAMA 245 (1981) 934
171. Wallace D.J., Metzger A.L., Stecher V.J., et al. Cholesterol-lowering effect of hydroxychloroquine in patients with rheumatic disease: effects on lipid metabolism. Am. J. Med. 89 (1990) 322
172. Ward M.M. Premature morbidity from cardiovascular and cerebrovascular disease in women with systemic lupus erythematosus. Arthritis Rheum. 42 (1999) 338
173. Wick G., Schett G., Amberger A., et al. Is atherosclerosis an immunologically mediated disease?. Immunol. Today 16 (1995) 27
174. Wijetunga M., and Rockson S. Myocarditis in systemic lupus erythematosus. Am. J. Med. 113 (2002) 419
175. Wilson V.E., Eck S.L., and Bates E.R. Evaluation and treatment of acute myocardial infarction complicating systemic lupus erythematosus. Chest 101 (1992) 420
176. Witztum J.L. The oxidation hypothesis of atherosclerosis. Lancet 344 (1994) 793
177. Yazici Z.A., Raschi E., Patel A., et al. Human monoclonal anti-endothelial cell IgG-derived from a systemic lupus erythematosus patient bind and activates human endothelium in vitro. Int. Immunol. 13 (2001) 349
178. Yurchak P.M., Levine S.A., and Gorlin R. Constrictive pericarditis in procainamide induced lupus erythematosus. Circulation 31 (1965) 113
179. Ziporen L., Goldberg I., Arad M., et al. Libman-Sacks endocarditis in the antiphospholipid syndrome. Immunopathologic findings in deformed heart valves. Lupus 5 (1996) 196